$3.19
0.072.24%
At close: -
$3.14
-0.05-1.57%
After Hours: 5:05 PM EDT
Comments
Loading...
Alto Neuroscience (ANRO) Forecast
NewsEarningsAlto Neuroscience (ANRO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAlto Neuroscience (NYSE:ANRO) Stock Quotes, Forecast and News Summary
Alto Neuroscience Stock (NYSE: ANRO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alto Neuroscience (ANRO) stock?
You can purchase shares of Alto Neuroscience (NYSE:ANRO) through any online brokerage.
Who are Alto Neuroscience (ANRO) competitors?
Other companies in Alto Neuroscience’s space includes: Third Harmonic Bio (NASDAQ:THRD), Cumberland (NASDAQ:CPIX), Bioage Labs (NASDAQ:BIOA), Rani Therapeutics Hldgs (NASDAQ:RANI) and Nutriband (NASDAQ:NTRB).
What is the forecast, or price target, for Alto Neuroscience (ANRO) stock?
Alto Neuroscience has a consensus price target of $19.67.
What is the current price for Alto Neuroscience (ANRO)?
The stock price for Alto Neuroscience (NYSE: ANRO) is $3.14 last updated February 21, 2025 at 5:05 PM EST.
Does Alto Neuroscience (ANRO) pay a dividend?
There are no upcoming dividends for Alto Neuroscience.
When is Alto Neuroscience (NYSE:ANRO) reporting earnings?
Alto Neuroscience’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Alto Neuroscience (ANRO) going to split?
There is no upcoming split for Alto Neuroscience.
What sector and industry does Alto Neuroscience (ANRO) operate in?
Alto Neuroscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.